Patel Prashant 4/A

What Happened
Prashant Patel, CEO of Wellgistics Health, Inc. (WGRX), received compensation on March 31, 2026 consisting of 5,000,000 newly issued common shares at $0.20 per share (valued at $1,000,000) and 5,000,000 warrants to purchase common stock (reported as a derivative award). Both items were reported on an amended Form 4 filed June 25, 2026. These were grants/awards (transaction code A), not open-market purchases or sales.

Key Details

• Transaction date: March 31, 2026; amended Form 4 filed June 25, 2026.
• Share grant: 5,000,000 common shares at $0.20 each — total reported value $1,000,000.
• Warrant award: 5,000,000 warrants reported as a derivative award (transaction reported at $0.00 consideration in the table; filing shows a reported derivative value of $500).
• Footnotes: Both the shares and warrants were issued as compensation for service and were exempt from registration under Section 4(a)(2) of the Securities Act.
• Ownership after transaction: Not disclosed in the information provided in this summary.
• Timeliness: This is an amended filing filed nearly three months after the transaction date, outside the typical two-business-day reporting window.

Context
These entries are compensatory grants to the CEO (awards), which are routine for executive compensation and do not by themselves indicate a buy or sell sentiment. The warrants are a derivative award—they give the holder the right to buy stock in the future under specified terms (exercise price and expiration not detailed here). Because this filing is an amendment and was filed late relative to the transaction date, investors may want to review the full amended Form 4 for any additional notes or previously omitted disclosures.